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Flow Chart for Management of Potential Contacts of Lassa Fever Patients
This document updates, with appropriate flow charts for management of potential 
contacts, the below text from CDC Health Advisory #210. Please reference the flowcharts 
at the end of the text.
Imported Lassa Fever Case in New Jersey
On September 2, 2004, results of laboratory testing performed at the Centers for Disease Control and Prevention 
(CDC) support a diagnosis of Lassa fever in a 38-year-old man who died in a New Jersey hospital on August 28. 
The patient had returned to the United States on August 24 after reportedly spending 5 months in Liberia, where 
Lassa fever is endemic. This is the first report of a travel-related case of Lassa fever in the United States since 
1989.
Lassa fever is an acute viral disease caused by Lassa virus, an arenavirus that is found throughout much of 
western Africa. The incubation period is usually about 10 days (range 6 to 21 days). The illness is characterized 
by fever, muscle aches, sore throat, nausea, vomiting, and chest and abdominal pain. Most (about 80%) human 
infections are mild or asymptomatic; in severe cases, hypotension or shock, hemorrhage, seizures, and death 
may occur. In disease-endemic areas, Lassa fever causes 100,000 to 300,000 human infections and 
approximately 5,000 deaths each year.
Lassa virus is spread to humans primarily through contact with the excreta of infected rodents. Person-to-person 
transmission is uncommon and occurs through direct unprotected contact with blood and other body fluids of an 
infected person. The virus is not spread by casual contact. Although several cases of imported Lassa fever have 
been reported previously, secondary transmission to other persons has been extremely rare among both travelers 
and healthcare workers in non-endemic areas.
Interim Guidance for Risk Assessment and Management
As part of the current investigation, CDC is working with the New Jersey Department of Health and Senior 
Services and other public health authorities to identify persons who might be at increased risk as a result of close 
contact with the patient or his body fluids. Public health authorities have established the following criteria for 
persons who might be at risk. As a precaution, a low-risk category for contact tracing and follow-up is defined 
below.
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High risk
• Exposure from a percutaneous injury (e.g., a needlestick or cut with a sharp object) to blood, tissue
or other body fluids that are potentially infectious (e.g., urine, vomitus, stool)
• Exposure from direct, unprotected contact with potentially infectious material (e.g., touching vomitus
with an ungloved hand)
• Exposure via mucosal exposure (e.g., to eyes, nose, mouth) to splashes or droplets of potentially
infectious blood and body fluids or sexual contact with a symptomatic patient.
Low risk
• Sharing a room or seated in a vehicle within 6 feet (i.e., coughing distance) of a potentially infectious
patient, without direct contact with potentially infectious material
• Providing routine medical care while using personal protective equipment appropriately
• Routine cleaning and laundry of contaminated linens and surfaces while using personal protective
equipment appropriately
• Transport of a potentially infectious patient or specimen without direct contact with potentially
infectious material
• Handling of clinical specimens while using personal protective equipment appropriately
Available information regarding the patient's travel itinerary from West Africa is as follows. The patient left 
Freetown, Sierra Leone, on Astraeus Flight 72, which departed 11:15 pm on August 23, 2004 and arrived at 
Gatwick Airport in London, England. He then traveled on Continental Flight 29, which departed London Gatwick 
Airport on August 24 and arrived in Newark, N.J., at 3:20 pm on August 24. CDC is working to obtain the 
passenger manifests for these flights and will provide passenger seating and contact information for those at risk 
to state health departments as soon as it is available. CDC also has contacted health officials in the United 
Kingdom and the World Health Organization about this case.
People who traveled on these flights and who think they may be at risk are advised to monitor their health for 21 
days after their travel (i.e., through September 18, 2004). Other people, including health-care workers, who think 
they might be at risk should monitor their health for 21 days after the last potential exposure. If fever of 101°F or 
greater develops, these persons should contact their state or local health departments for further instructions.
This investigation is ongoing. At this time public health authorities are attempting to identify persons at risk for 
exposure. Persons in New Jersey who believe they may be at risk should contact the New Jersey health 
department hotline at 1-866-234-0964. Persons residing in other states should contact their state or local health 
departments. Additional information about Lassa fever and patient management is provided in the flow charts at 
the end of this document.
Laboratory Diagnostics and Additional Information
Common causes of fever should be included in the differential diagnosis in addition to consideration of Lassa 
fever as an etiology. Specific diagnostic testing for Lassa fever is available at CDC (phone: 404-639-1115).
Additional information about Lassa fever testing is available on the CDC website at
http://www.cdc.gov/ncidod/dvrd/spb/mnpages/dispages/lassaf.htm. CDC information about infection control is 
available at http://www.cdc.gov/ncidod/hip/.
For additional information about the case in New Jersey, please see the website of the New Jersey Department of 
Health and Senior Services http://www.state.nj.us/health/ or contact the health department's hotline at 1-866-234­
0964. For more information about Lassa fever, please see the CDC website at http://www.cdc.gov.
The Centers for Disease Control and Prevention (CDC) protects people's health and safety by preventing and 
controlling diseases and injuries; enhances health decisions by providing credible information on critical health 
issues; and promotes healthy living through strong partnerships with local, national and international
organizations.
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